Cargando…

Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials

The Colorectal Cancer Subtyping Consortium identified four gene expression consensus molecular subtypes, CMS1 (immune), CMS2 (canonical), CMS3 (metabolic), and CMS4 (mesenchymal), using multiple microarray or RNA-sequencing datasets of primary tumor samples mainly from early stage colon cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontana, E, Eason, K, Cervantes, A, Salazar, R, Sadanandam, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503627/ https://www.ncbi.nlm.nih.gov/pubmed/30796810 http://dx.doi.org/10.1093/annonc/mdz052

Ejemplares similares

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
por: Ragulan, Chanthirika, et al.
Publicado: (2019)

The Consensus Molecular Subtypes of Colorectal Cancer
por: Guinney, Justin, et al.
Publicado: (2015)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significance
por: Eason, Katherine, et al.
Publicado: (2018)

Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study
por: Borelli, B., et al.
Publicado: (2021)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer
por: Amirkhah, Raheleh, et al.
Publicado: (2023)

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
por: Valenzuela, Guillermo, et al.
Publicado: (2021)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
por: Eide, Peter W., et al.
Publicado: (2017)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
por: Sawayama, Hiroshi, et al.
Publicado: (2020)

Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
por: Chowdhury, Saikat, et al.
Publicado: (2021)

A Machine-Learning Tool Concurrently Models Single Omics and Phenome Data for Functional Subtyping and Personalized Cancer Medicine
por: Nyamundanda, Gift, et al.
Publicado: (2020)

Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
por: Purcell, Rachel V., et al.
Publicado: (2017)

Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: ten Hoorn, Sanne, et al.
Publicado: (2021)

Consensus Molecular Subtypes (CMS) in Metastatic Colorectal Cancer - Personalized Medicine Decision
por: Rebersek, Martina
Publicado: (2020)

YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes
por: Mouillet-Richard, Sophie, et al.
Publicado: (2020)

Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer
por: Lu, Yujie, et al.
Publicado: (2023)

Is the tumour microenvironment a critical prognostic factor in early-stage colorectal cancer?
por: Nyamundanda, G, et al.
Publicado: (2019)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
por: Sveen, Anita, et al.
Publicado: (2017)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal Cancer
por: Nunez, Sha’Kayla K., et al.
Publicado: (2021)

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
por: van den Bulk, Jitske, et al.
Publicado: (2019)

The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer
por: Tanjak, Pariyada, et al.
Publicado: (2023)

Identifying essential genes in genome-scale metabolic models of consensus molecular subtypes of colorectal cancer
por: Cheng, Chao-Ting, et al.
Publicado: (2023)

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
por: Okita, Akira, et al.
Publicado: (2018)

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
por: Sirinukunwattana, Korsuk, et al.
Publicado: (2021)

Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
por: González-Montero, Jaime, et al.
Publicado: (2023)

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer
por: van den Berg, Inge, et al.
Publicado: (2021)

Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer
por: Nguyen, Huu-Giao, et al.
Publicado: (2021)

Consensus molecular subtypes of primary colon tumors and their hepatic metastases
por: Lau, Yee Chen, et al.
Publicado: (2021)

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
por: Laoukili, Jamila, et al.
Publicado: (2022)

CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer
por: Loupakis, Fotios, et al.
Publicado: (2019)

Molecular subtyping of Alzheimer’s disease with consensus non-negative matrix factorization
por: Zheng, Chunlei, et al.
Publicado: (2021)

Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets
por: Paz-Cabezas, Mateo, et al.
Publicado: (2022)

A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer
por: Myte, Robin, et al.
Publicado: (2020)

Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes
por: Sousa-Squiavinato, Annie Cristhine Moraes, et al.
Publicado: (2021)

Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer
por: Bonilla, Carlos Eduardo, et al.
Publicado: (2023)

De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
por: Moosavi, Seyed H., et al.
Publicado: (2021)

Body mass index and molecular subtypes of colorectal cancer
por: Murphy, Neil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k8umijddn59hh2n10e90cartp5